Hypersomnia (excessive sleepiness)

Key characteristics and symptoms

Typical features include persistent drowsiness, unintended naps during the day, prolonged night sleep yet nonrefreshing rest, and difficulty waking. People may report cognitive slowing, memory lapses, poor concentration, and slowed reaction times. In some disorders associated with hypersomnia there are additional symptoms such as cataplexy in narcolepsy, but many cases present with generalized sleepiness without distinctive signs.

Causes and types

Clinicians divide hypersomnia into primary and secondary forms. Primary hypersomnias arise from abnormalities in the brain's sleep–wake control systems; examples include narcolepsy and idiopathic hypersomnia. Secondary hypersomnias are the result of other medical, psychiatric or environmental factors.

• Common medical contributors: obstructive sleep apnea (sleep apnea), head injury, neurodegenerative disease, endocrine disorders.
• Neurological and psychiatric associations: narcolepsy (narcolepsy), epilepsy and postictal sleepiness after seizures, and mood disorders such as depression (mood disorders).
• Medications and substances: sedatives, some antihistamines and alcohol or other drugs can produce or worsen hypersomnia (medications and substances).
• Other causes: short sleep schedules, circadian rhythm disorders, or loss of consciousness from events such as fainting or seizures (transient loss of consciousness) and conditions like epilepsy (epilepsy).

Diagnosis

Evaluation starts with a detailed sleep history, medication review and assessment of mood and medical illnesses. Objective testing often includes overnight polysomnography to exclude sleep-disordered breathing and periodic limb movements, followed by daytime tests such as the multiple sleep latency test (MSLT) to quantify sleepiness and identify pathological sleep onset REM periods. Laboratory tests and neuroimaging may be used when an underlying condition is suspected.

Treatment and management

Therapy targets the underlying cause when possible and aims to improve daytime alertness and safety. Approaches include behavioral measures (regular sleep schedule, sleep hygiene, planned naps), treatment of contributory disorders (for example continuous positive airway pressure for obstructive sleep apnea), and medications. Pharmacologic options may include wake-promoting agents and stimulant medications; specific drugs and dosing depend on diagnosis and comorbidities. In narcolepsy certain agents such as sodium oxybate can address both sleepiness and disturbed nocturnal sleep. Careful review of current medications and substance use is important because many agents can exacerbate sleepiness.

Impact, risks and notable distinctions

Persistent hypersomnia can impair driving and workplace safety, reduce quality of life, and worsen mood and cognition. It should be distinguished from fatigue—a subjective lack of energy that may not be relieved by sleep—and from insomnia. Epidemiological estimates vary by population, and while primary hypersomnias are relatively uncommon, secondary hypersomnia resulting from sleep apnea, medications or psychiatric disease is frequently encountered in clinical practice.

History and clinical context

Recognition of excessive sleepiness as a medical problem developed alongside modern sleep medicine during the 20th century as diagnostic tools such as polysomnography became available. Advances in understanding neurotransmitters that regulate wakefulness have clarified mechanisms for some primary hypersomnias and guided the development of targeted treatments. Ongoing research seeks better diagnostic markers and safer, more effective therapies.

For people experiencing persistent daytime sleepiness, a structured medical assessment is recommended to identify treatable causes and reduce risks. Reliable information and multidisciplinary care help most patients achieve meaningful improvement.